Results of Dasatinib Therapy in Patients With Early Chronic-Phase Chronic Myeloid Leukemia

PURPOSE: Dasatinib is effective therapy for chronic myeloid leukemia (CML) after imatinib failure. In this study, we investigate the efficacy of dasatinib as initial therapy for patients with CML in early chronic phase. PATIENTS AND METHODS: Patients with newly diagnosed CML in early chronic phase w...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Cortes, Jorge E., Jones, Dan, O'Brien, Susan, Jabbour, Elias, Ravandi, Farhad, Koller, Charles, Borthakur, Gautam, Walker, Brenda, Zhao, Weiqiang, Shan, Jianqin, Kantarjian, Hagop
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: American Society of Clinical Oncology 2010
Pynciau:
Original Reports
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC2815702/
https://ncbi.nlm.nih.gov/pubmed/20008620
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2009.25.4920
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg